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Takayuki Ohyoshi, * Keisuke Mitsugi, Tatsuya Higuma, Fumitaka Ichimura,
Masahito Yoshida and Hideo Kigoshi *
We have established a concise and scalable synthetic pathway for phelligridins A (1), C (2) and D (3). The
synthetic highlights were Suzuki–Miyaura coupling and aldol-type condensation of a-pyrone. Phelligridin
A was synthesized in four steps, while phelligridins C and D were each synthesized in six steps.
Furthermore, we have revealed that the whole structure is essential for the cytotoxicity of phelligridins.Phelligridin A (1) is a polyphenol isolated from the fruiting body
of Phellinus igniarius, a fungus collected in Liaoning Province,
China in 2003 (Fig. 1).1 A year later, analogs of 1, phelligridins C
(2) and D (3), were also isolated from the fungus.2 Also in 2004,
meshimakobnols A and B were independently isolated from the
Japanese mushroom of the same genus (Phellinus linteus).
Meshimakobnols A and B were found to be identical to 3 and 2,
respectively.3 Structurally, they possess a tricyclic fused ring
system including two adjacent a-pyrone rings. In addition, they
inhibit the cell growth of a variety of cancer cells.2,4However, the
reported values of cytotoxicity against lung cancer A549 cells
diﬀered greatly. Furthermore, hispidin (4), a similar pyrone
compound to phelligridin D (3), inhibits in a dose-dependent
manner the activity of BACE 1, which produces amyloid b,
a causative biomolecule of Alzheimer's disease.5 Recently, Shi-
gemori and co-workers reported on the inhibitory eﬀect of), C (2), D (3), and hispidin (4).
f Pure and Applied Sciences, University of
1, Japan. E-mail: kigoshi@chem.tsukuba.
ESI) available: Experimental protocols,
a of all new compounds. See DOI:
hemistry 2019phelligridin D (3) on the aggregation of 42-mer amyloid b.6
However, the biological studies were limited to those of the
natural products or their congeners. Because a structure–
activity relationship study on phelligridins/meshimakobnols is
expected to provide lead compounds for cancer and Alzheimer's
disease, we decided to establish an adaptable synthetic route for
their structure–activity relationships. Herein, we described
a concise and scalable total synthesis of phelligridins A (1), C
(2), and D (3) and their biological evaluation.
The retrosynthetic pathway of phelligridins is shown in
Scheme 1. Phelligridins C (2) and D (3) would be derived from
dimethylphelligridin A (6) by aldol-type condensation with the
corresponding benzaldehyde. Dimethylphelligridin A (6) would
be synthesized from boronate ester 7 and bromopyrone 8 by
Suzuki–Miyaura coupling. In this synthetic plan, several
analogs of the phelligridins can be synthesized by changing the
two coupling partners of the aldol-type condensation and
Suzuki–Miyaura coupling.
Our synthesis of phelligridins started from the commercially
available a-pyrone 9 (Scheme 2). Bromination7 and protection of
9 gave the bromopyrone 8, a precursor of Suzuki–Miyaura
coupling. The coupling reaction between 8 and boronate ester 7
(ref. 8) followed by removal of the MOM group and concomitantScheme 1 Retrosynthetic pathway of phelligridins.
RSC Adv., 2019, 9, 7321–7323 | 7321
Scheme 2 Synthesis of dimethylphelligridin A (6) and aldol-type
reaction.
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View Article Onlinelactonization gave dimethylphelligridin A (6) as a precursor of
the aldol-type condensation. Next, we examined the synthesis of
phelligridin D (3). The aldol-type reaction of dimethylphelli-
gridin A (6) and aldehyde 5a was carried out under reported
conditions, LHMDS/THF9 or tBuOK/DMF.10 However, under
these conditions, 6 was insoluble in solvent, and the reaction
did not proceed.
Therefore, we then tried aldol-type reaction with 10 (Scheme
3). The aldol reaction of 10 and 5a gave the aldol 12 in moderate
yield. Subsequently, the aldol 12 was dehydrated viamesylation,
and the MOM group was removed to obtain tetramethylphelli-
gridin D (14). Finally, removal of the four methyl groups in 14
under HCl$py gave phelligridin D (3). Although we had achieved
the total synthesis of 3, there are three problems needed to be
solved to adapt the synthetic route to a scalable preparation.Scheme 3 Total synthesis of phelligridin D (3).
7322 | RSC Adv., 2019, 9, 7321–7323Firstly, the solubility of phelligridin D, as well as that of the
synthetic intermediates from compound 10, was remarkably
low in a variety of solvents. Therefore, there were restrictions on
reaction conditions and purication methods. Secondly, isom-
erization of the trans olen in 3 and 14 occurred easily by light.
Finally, the demethylation of 14 required severe reaction
conditions. All the aforementioned drawbacks resulted in a low
overall yield for phelligridin D (3). In order to solve these three
problems, we decided to protect the phenolic hydroxy groups as
MOM ethers.
Suzuki–Miyaura coupling of bromopyrone 8 and di-MOM
boronate ester 15 gave the coupling compound 16 (Scheme 4).
The aldol-type reaction with di-MOM aldehyde 17 and dehy-
dration aﬀorded 18. In this case, the aldol-type reaction of 16
proceeded in high yield presumably due to improved solubility
of 16. Finally, phelligridin D (3) was synthesized by deprotection
of ve MOM groups under mild acidic conditions.
Having established a synthetic route for phelligridin D (3),
the total synthesis of phelligridin A (1) and C (2) was carried out
using synthetic intermediate 16 (Scheme 5). Removal of the
three MOM groups in 16 gave phelligridin A (1). In addition,
phelligridin C (2) was synthesized in three steps from 16 by
changing the aldehyde of the aldol-type reaction to 19.
With the synthetic samples in hand, the cytotoxicity against
A549 cells and HeLa S3 cells of phelligridins were evaluated
(Table 1). Phelligridin C (2) and D (3) showed cytotoxicity
against A549 cells with IC50 of 1.6 mM and 1.1 mM, respectively.
These values were closer to those reported by Nagatsu than by
Shi.11 On the other hand, phelligridin A (1), a le segment of
phelligridin C (2) and D (3), and hispidin (4), a right segment of
phelligridin D (3), show no cytotoxicity. These results showed
that the combination of le and right segments is essential for
the cytotoxicity of the phelligridins. In addition, we evaluated
cytotoxicity against human cervical cancer cells. In cytotoxicityScheme 4 Concise total synthesis of phelligridin D (3).
This journal is © The Royal Society of Chemistry 2019
Scheme 5 Total syntheses of phelligridins A (1), C (2).
Table 1 Cytotoxicity of phelligridins A, C, D, and hispidin
Cpd
A549 cellsa (mM)
HeLa S3 cells
(mM)
Syn. Nat. Syn.
IC50 IC50 GI50 IC50
1 >100 >0.192b — >100
2 1.6 0.012b 15.0c 3.0
3 1.1 0.016b 22.6c 2.1
4 >100 — — >100
a See ESI. b Ref. 2. c Ref. 4.
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View Article Onlineagainst HeLa S3 cells, the same tendencies were observed as
well.
Conclusions
We have established a concise and scalable synthetic pathway
for phelligridins A (1), C (2), and D (3). The synthetic highlights
were Suzuki–Miyaura coupling and aldol-type condensation of
a-pyrone. Phelligridin A was synthesized in four steps, whileThis journal is © The Royal Society of Chemistry 2019phelligridins C and D were each synthesized in six steps.
Furthermore, we have investigated their cytotoxicity and
revealed that the whole structure is essential for the cytotoxicity
of phelligridins. A structure–activity relationships study based
on this synthetic route is ongoing in our laboratory.Conﬂicts of interest
There are no conicts to declare.Acknowledgements
This work was supported by Grants-in-Aid for Scientic
Research (Grant Number JP26242073) from Japanese Society for
the Promotion of Science (JSPS).Notes and references
1 S.-Y. Mo, Y.-C. Yang, W.-Y. He and J.-G. Shi, Chin. Chem. Lett.,
2003, 14, 704.
2 S.-Y. Mo, S.-J. Wang, Y.-C. Yang, X.-G. Chen and J.-G. Shi, J.
Nat. Prod., 2004, 67, 823.
3 A. Nagatsu, S. Itoh, R. Tanaka, S. Kato, M. Haruna,
K. Kishimoto, H. Hirayama, Y. Goda, H. Mizukami and
Y. Ogihara, Tetrahedron Lett., 2004, 45, 5931.
4 K. Kojima, T. Ohno, M. Inoue, H. Mizukami and A. Nagatsu,
Chem. Pharm. Bull., 2008, 56, 173.
5 I.-K. Lee and B.-S. Yun, J. Antibiot., 2011, 64, 349.
6 Y. Aihara, A. Kawaguchi, M. Hanaki, K. Murakami, K. Irie
and H. Shigemori, Heterocycles, 2017, 91, 1280.
7 P. D. March, M. Mareno-Manas, R. Pi, I. Ripoll and
F. Sanchez-Ferrando, J. Heterocycl. Chem., 1985, 22, 1537.
8 C. Genes, S. Michel, F. Tillequin and F. H. Poree,
Tetrahedron, 2009, 65, 10009.
9 J. Preindl, S. Schulthoﬀ, C. Wirts, J. Lingnau and A. Furstner,
Angew. Chem., Int. Ed., 2017, 56, 7525.
10 G. A. Kraus and U. K. Wanninayake, Tetrahedron Lett., 2015,
56, 7112.
11 Very recently, we got the personal communication from Shi
that the unit of cytotoxicity was wrong in ref. 2 and the values
of cytotoxicity should be given in mg mL1. The revised
values of cytotoxicity against A549 cells are as follows: 2,
4.4 mM (0.012 mg mL1); 3, 6.1 mM (0.016 mg mL1). Our
results correspond to the revised values.RSC Adv., 2019, 9, 7321–7323 | 7323
